Business ❯ Healthcare

Pharmaceuticals

Drug Development Clinical Trials Market Competition Weight Loss Drugs Drug Pricing Biotechnology Oncology Manufacturing Market Trends Acquisitions

Novo Nordisk Lifts Outlook After Wegovy Pill Powers Big Q1 Beat

Price cuts threaten to blunt the payoff from surging prescriptions.

Lifecore Reaffirms 2026 Outlook After Q1 Adds Three Site Transfers

Stories older than 24h

ADC Therapeutics Reports Higher Q1 Sales and Lower Costs as Zenlonta Readouts Near

Nuvation Bio Reports Q1 Growth as Iptrozy Moves Earlier in ROS1 Lung Cancer Care

Axsome Reports 57% Q1 Sales Jump as FDA Clears Auvelity for Alzheimer’s Agitation

Purdue Pharma Shuts Down as $7.4 Billion Opioid Settlement Takes Effect

LEO Pharma to Acquire Replay in $50 Million Gene-Therapy Deal

Merck Reports Q1 Loss From Cidara Charge as Sales Beat and 2026 Outlook Rises

Cardinal Health Lifts 2026 Profit Outlook After Q3 Beat Despite Sales Miss

AstraZeneca Tops Q1 Forecasts, Reaffirms 2026 Outlook as Oncology Fuels Growth

Regeneron Tops Q1 Estimates as Dupixent and Libtayo Outpace Eylea

AbbVie Tops Q1 and Raises 2026 Outlook as Skyrizi and Rinvoq Offset Humira Decline

Lilly’s Foundayo Start Trails Wegovy as Street Stays Positive

Pfizer Sets 2026 Targets and Marks 350th Straight Dividend

Ligand to Buy XOMA Royalty for $739 Million

Cost Plus Drugs and Humana’s CenterWell Strike Employer Pharmacy Partnership

HHS Push to Ease Peptide Curbs Spurs FDA Review and Investor Bets

Sun Pharma Said to Make $13 Billion All-Cash Offer for Organon

Lilly Shares Slip as Foundayo’s Second-Week Prescriptions Trail Wegovy

Gossamer Bio Investors Sought to Lead Lawsuit After Seralutinib Trial Failure